SPDR S&P Pharmaceuticals ETF
XPH
XPH
60 hedge funds and large institutions have $204M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 7 closing their positions.
Holders
60
Holders Change
-1
Holders Change %
-1.64%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
18
Reduced
19
Closed
7
Calls
$296K
Puts
$2K
Net Calls
+$294K
Net Calls Change
+$287K
Top Buyers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$36.3M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$40.1M |
| 3 |
CS
3
Credit Suisse
Zurich,
Switzerland
|
$57.5M |
| 4 |
4
Goldman Sachs
New York
|
$30.4M |
| 5 |
RJA
5
Raymond James & Associates
St Petersburg,
Florida
|
$1.4M |
